These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36450739)

  • 41. Increased risk of herpes zoster in patients with psoriasis: A longitudinal follow-up study using a national sample cohort.
    Min C; Yoo DM; Kim M; Choi HG
    Australas J Dermatol; 2021 May; 62(2):183-189. PubMed ID: 33527370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Incidence of Psoriasis in Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Matched Cohort Study.
    Moon JM; Lee JY; Koh SJ; Park H; Kang S; Soh H; Lee HJ; Im JP; Kim JS
    Dermatology; 2021; 237(3):330-337. PubMed ID: 33556947
    [TBL] [Abstract][Full Text] [Related]  

  • 43. An increased risk of non-melanoma skin cancer during TNF-inhibitor treatment in psoriasis patients compared to rheumatoid arthritis patients probably relates to disease-related factors.
    van Lümig PP; Menting SP; van den Reek JM; Spuls PI; van Riel PL; van de Kerkhof PC; Fransen J; Kievit W; de Jong EM
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):752-60. PubMed ID: 25229823
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The risk of melanoma and hematologic cancers in patients with psoriasis.
    Reddy SP; Martires K; Wu JJ
    J Am Acad Dermatol; 2017 Apr; 76(4):639-647.e2. PubMed ID: 27876302
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Risk of incident cataract in patients with psoriasis: A population-based cohort study.
    Cheng CY
    J Dermatol; 2022 Mar; 49(3):359-367. PubMed ID: 34862667
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Risk of major adverse cardiovascular events and all-cause mortality among patients with psoriatic disease treated with tumor necrosis factor-α and interleukin-12/23 inhibitors: a nationwide population-based cohort study in Korea.
    Cho H; Kim YJ; Moon IJ; Lee WJ; Won CH; Lee MW; Chang SE; Jung JM
    J Dermatolog Treat; 2024 Dec; 35(1):2321194. PubMed ID: 38403279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduced frequency of non-melanoma skin cancer in 72,739 patients with psoriasis: a retrospective study.
    Paradisi A; Didona B; Tabolli S; Ricci F; Sobrino L; Panebianco A; Abeni D
    Eur J Dermatol; 2017 Aug; 27(4):359-362. PubMed ID: 28524053
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Increased risk of psoriasis in subjects with abdominal obesity: A nationwide population-based study.
    Han JH; Lee JH; Han KD; Kim HN; Bang CH; Park YM; Lee JY; Kim TY
    J Dermatol; 2019 Aug; 46(8):695-701. PubMed ID: 31149744
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased risk of atherosclerotic cardiovascular disease among patients with psoriasis in Korea: A 15-year nationwide population-based cohort study.
    Jung KJ; Kim TG; Lee JW; Lee M; Oh J; Lee SE; Chang HJ; Jee SH; Lee MG
    J Dermatol; 2019 Oct; 46(10):859-866. PubMed ID: 31432567
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk of malignancy in patients with psoriasis receiving systemic medications: A nested case-control study.
    Chou YJ; Wu CY; Pan TY; Wu CY; Chang YT
    Dermatol Ther; 2022 Nov; 35(11):e15804. PubMed ID: 36068977
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Risks of hypertension associated with cyclosporine, nonsteroidal anti-inflammatory drugs, and systemic glucocorticoids in patients with psoriasis: a nationwide population-based nested case-control study in Taiwan.
    Lee MS; Chang CH; Lin RY; Lai MS
    Pharmacoepidemiol Drug Saf; 2016 Feb; 25(2):133-40. PubMed ID: 26521982
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of Overall and Specific Cancer Risks in Patients With Hidradenitis Suppurativa.
    Jung JM; Lee KH; Kim YJ; Chang SE; Lee MW; Choi JH; Won CH; Lee WJ
    JAMA Dermatol; 2020 Aug; 156(8):844-853. PubMed ID: 32459291
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The risk of treated anxiety and treated depression among patients with psoriasis and psoriatic arthritis treated with apremilast compared to biologics, DMARDs and corticosteroids: a cohort study in the United States MarketScan database.
    Vasilakis-Scaramozza C; Persson R; Hagberg KW; Jick S
    J Eur Acad Dermatol Venereol; 2020 Aug; 34(8):1755-1763. PubMed ID: 31981426
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk of Dementia Among Individuals With Psoriasis: A Nationwide Population-Based Cohort Study in Taiwan.
    Huang KL; Yeh CC; Wu SI; Huang KY; Yang YH; Kuo TY; Liang HY; Lee YC; McIntyre RS; Lee Y; Weng JC; Chen VC
    J Clin Psychiatry; 2019 May; 80(3):. PubMed ID: 31091030
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Drug survival of adalimumab, ustekinumab and secukinumab in patients with psoriasis: a prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR).
    Yiu ZZN; Mason KJ; Hampton PJ; Reynolds NJ; Smith CH; Lunt M; Griffiths CEM; Warren RB;
    Br J Dermatol; 2020 Aug; 183(2):294-302. PubMed ID: 32124442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hydrochlorothiazide use and the risk of skin cancer in patients with hypertensive disorder: a nationwide retrospective cohort study from Korea.
    Park E; Lee Y; Jue MS
    Korean J Intern Med; 2020 Jul; 35(4):917-928. PubMed ID: 31842528
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The risk of malignancy among biologic-naïve pediatric psoriasis patients: A retrospective cohort study in a US claims database.
    Gu Y; Nordstrom BL
    J Am Acad Dermatol; 2017 Aug; 77(2):293-301.e1. PubMed ID: 28623045
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of Risk of Major Adverse Cardiovascular Events With Biologic Therapy in Patients With Psoriasis.
    Bissonnette R; Kerdel F; Naldi L; Papp K; Galindo C; Langholff W; Tang KL; Szapary P; Fakharzadeh S; Srivastava B; Goyal K; Gottlieb AB
    J Drugs Dermatol; 2017 Oct; 16(10):1002-1013. PubMed ID: 29036254
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cardiovascular outcomes and systemic anti-inflammatory drugs in patients with severe psoriasis: 5-year follow-up of a Danish nationwide cohort.
    Ahlehoff O; Skov L; Gislason G; Gniadecki R; Iversen L; Bryld LE; Lasthein S; Lindhardsen J; Kristensen SL; Torp-Pedersen C; Hansen PR
    J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1128-34. PubMed ID: 25303139
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased risk for incident thyroid diseases in people with psoriatic disease: A cohort study.
    Wang SH; Wang J; Lin YS; Tung TH; Chi CC
    J Am Acad Dermatol; 2019 Apr; 80(4):1006-1012. PubMed ID: 30528501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.